Phase 1 Randomized Trial Supports Lovastatin as a Potential Primary Treatment for Disseminated Superficial Actinic Porokeratosis
1. Disseminated superficial actinic porokeratosis (DSAP) was improved in both treatment groups (i.e., lovastatin-cholesterol and lovastatin alone) with no serious ...